HomeANRO • NYSE
add
Alto Neuroscience Inc
Previous close
$13.36
Day range
$13.16 - $13.79
Year range
$1.60 - $16.49
Market cap
417.82M USD
Avg Volume
1.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.95M | -20.84% |
Net income | -14.18M | 15.50% |
Net profit margin | — | — |
Earnings per share | -0.52 | — |
EBITDA | -14.79M | 21.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.82M | -24.15% |
Total assets | 147.01M | -23.28% |
Total liabilities | 35.45M | 33.49% |
Total equity | 111.56M | — |
Shares outstanding | 31.07M | — |
Price to book | 3.25 | — |
Return on assets | -24.52% | — |
Return on capital | -26.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -14.18M | 15.50% |
Cash from operations | -9.92M | 15.42% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 153.00K | -88.38% |
Net change in cash | -9.77M | 14.46% |
Free cash flow | -6.00M | 26.82% |
About
Founded
2019
Website
Employees
76
